Navigation Links
PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124
Date:7/16/2008

data from recently completed Phase 2a studies in adult and pediatric CF patients at the European Cystic Fibrosis Conference. Results from these studies demonstrated statistically significant improvements in the primary outcome measure-nasal potential difference (NPD)-across a variety of age ranges, geographies, and nonsense mutation types. In the three-month, Phase 2a extension study of adult patients, results demonstrated a statistically significant mean decrease [28 percent] in the frequency of cough, one of the most prominent and burdensome CF-related symptoms.

About Cystic Fibrosis

Cystic fibrosis (CF) is a life-threatening genetic disease that causes serious lung infections and digestive complications. According to the Cystic Fibrosis Foundation, CF affects approximately 30,000 adults and children in the United States and nearly 70,000 people worldwide. CF occurs in approximately one of every 3,500 live births, with approximately 1,000 new cases diagnosed each year in the United States. There is a commercially available genetic test to determine if a patient's CF is caused by a nonsense mutation, and it is estimated that nonsense mutations are the cause of CF in approximately 10 percent of patients in the United States. There is currently no available therapy to correct defective CFTR production and function. Instead, available treatments for CF are designed to alleviate the symptoms of the disease. These treatments include chest physical therapy to clear the thick mucus from the lungs, antibiotics to treat lung infections and a mucus-thinning drug designed to reduce the number of lung infections and improve lung function. In addition, the majority of CF patients take pancreatic enzyme supplements to assist with food absorption in digestion. There is a significant unmet medical need for treatments for the underlying cause of CF. More information regarding CF is available through the Cystic Fibrosis Foundation ( '/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
2. Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients
3. Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
4. Silence Therapeutics Announces Board Changes
5. Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
6. Data Presented at American Headache Societys Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics Tezampanel
7. TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate
8. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
9. Pilot Therapeutics Announces Relaunch as Gene Smart(TM) Health
10. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
11. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... VANCOUVER, British Columbia and MENLO ... DelMar Pharmaceuticals, Inc. , (OTCQB: DMPI), developer of ... presenting company at the 16th Annual Rodman & Renshaw ... & Co., LLC. The presentation will take place Tuesday, September ... Salon (4th floor) at the New York Palace Hotel ...
(Date:8/27/2014)... FAIRFAX, Va. , Aug. 27, 2014 ... in the legs due to buildup of fatty plaque ... expected in the aging patient population and in incidences ... Radiology offers its Lower Extremity Arterial RevascularizatioN ... Ariz. Endovascular specialists and interested residents and ...
(Date:8/27/2014)... Research and Markets  has announced the ... 2014" report to their offering. ... professional and in-depth study on the current state of ... provides a basic overview of the industry including definitions, ... market analysis is provided for the international markets including ...
Breaking Medicine Technology:DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Global Pulse Oximeter Industry Report 2014 2
... 6, 2011 Agendia, an innovative molecular diagnostics ... paraffin embedded tissue technology applied to their Symphony™ ... in a paraffin embedded tissue format offers their ... development and validation found in Agendia,s breast cancer ...
... 6, 2011  TRACE released the 2011 BRIBEline United ... demands for bribes reported in specific countries.  Previous reports ... Ukraine, Russia, India and China. "The ... contribution to the prevention of bribery," said TRACE Founder ...
Cached Medicine Technology:Agendia Introduces the SYMPHONY™ Breast Cancer Profile With Paraffin Embedded Tissue 2TRACE Releases Report on Bribe Demands in the United States 2TRACE Releases Report on Bribe Demands in the United States 3
(Date:8/27/2014)... (PRWEB) August 27, 2014 The Latinos ... 5th, 6th and 7th at the Florida State Fair ... celebrates all Latino art and cultures from around the ... their platinum sponsor Go Smart Mobile and Univision Mobile, ... Festival is expecting an estimate of 4,000 people from ...
(Date:8/27/2014)... 27, 2014 New Jersey’s own Morgan ... Ridgewood County Club during The Barclays – and thanks ... of the tournament’s four rounds, stepped his way into ... Cross Blue Shield of New Jersey (Horizon BCBNSNJ) Walking ... Wyckoff native playing before family and friends at the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Seventy-three members ... Pharmacy (SoP) celebrated the beginning of their careers as ... Saturday, August 23. Students entering a four-year PharmD program ... care ?to welcome them into the profession as colleagues ... ceremony held at the Garrison Theater in Claremont, Calif., ...
(Date:8/27/2014)... therapy has spawned a prevalent but preventable side effect: ... according to a study by a Yale School of ... published in the Aug. 27 online issue of the ... to severe hot flashes also called vasomotor symptoms ... with VMS experience more than feeling hot; other frequently ...
(Date:8/27/2014)... Dennis Thompson HealthDay Reporter ... who has been mugged in a dark alley will likely ... a fear of being attacked. But neuroscientists working with ... memories are linked with positive and negative emotions. And in ... attached to a memory. In essence, they made once-reluctant ...
Breaking Medicine News(10 mins):Health News:Marc Anthony to Perform at "Nieves Productions" Latinos in Action Festival 2Health News:Morgan Hoffmann, PGA TOUR Pro & Wyckoff Native, golfs and walks his way to top 10 finish at The Barclays while raising additional $7,500 for charity 2Health News:Founding Class of the KGI School of Pharmacy Formally Welcomed into the Profession at a Traditional White Coat Ceremony 2Health News:The high cost of hot flashes: Millions in lost wages preventable 2Health News:Scientists 'Rewrite' Bad Memories in Mice 2Health News:Scientists 'Rewrite' Bad Memories in Mice 3
... FRIDAY, March 4 (HealthDay News) -- A diet rich in foods ... stroke by 21 percent and may also lower your risk of ... include bananas and other fruits and vegetables, as well as fish, ... sweet potato and tomato paste top the list, according to the ...
... designed to assist weight loss by limiting the amount of ... It has been used for several years to treat obesity ... Clinical Obesity reveals that bariatric surgery can result in ... Aikenhead of the International Association for the Study of Obesity ...
... News)-- Men need more support before and after their child ... they were happy to attend childbirth classes for their partner,s ... and did not have a ready outlet for their own ... for a University of Gothenburg thesis by midwife Asa Premberg ...
... ALS or more popularly, Lou Gehrig,s disease, is a ... brain and spinal cord neurons, resulting in the gradual ... In a new paper, published in the ... Nature Neuroscience , a team of scientists at the ...
... , FRIDAY, March 4 (HealthDay News) -- Poor ... of people worldwide at risk for early death, a ... treatment and management in Colombia, England, Iran, Mexico, Scotland, ... of U.S. adult diabetics -- more than 16 million ...
... Professor of Molecular & Cell Biology at Boston University ... of Microbiology at Boston University School of Medicine discovered ... of gene expression. The study describing this work titled, ... Premature Transcription Termination," appears in the March 4 issue ...
Cached Medicine News:Health News:Potassium-Rich Foods May Cut Stroke, Heart Disease Risk 2Health News:Potassium-Rich Foods May Cut Stroke, Heart Disease Risk 3Health News:Study Finds Men Need More Support Before, After Child Birth 2Health News:Loss of key protein boosts neuron loss in ALS 2Health News:Diabetes Often Not Diagnosed or Treated Properly 2Health News:Novel mechanism for control of gene expression revealed 2
Open wire style 16 mm blade with a wing tip twist giving the surgeon better on-axis accessibility....
Angled upward 45 degrees for temporal approach. Open 14 mm blades....
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: